Search clinical trials for: KD101

Total 9 results

Kwang Dong Pharmaceutical co., ltd.

Unknown

To Evaluate the Safety, Tolerability, PK, PK-PD Relation of KD101 in the Fed State in Obese or Overweight Subjects

Obesity

Korea, Republic of
Kwang Dong Pharmaceutical co., ltd.

Completed

Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects

Drug Toxicity

Korea, Republic of
Seoul National University Hospital

Completed

A Phase I Study to Investigate the ADME of KD101

Obesity
Pachyonychia Congenita Project

Completed

Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita

Pachyonychia Congenita

United States
Moberg Pharma AB

Completed

A Clinical Investigation on Early Visible Effects of Application of K101 During 8 Weeks on Discoloured and Deformed Nails Resulting From Onychomycosis

Onychomycosis
Cidara Therapeutics Inc.

Completed

RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections

Mycoses | Candidiasis, Vulvovaginal | Yeast Infection | Moniliasis, Vulvovaginal | Vaginitis, Monilial

United States
Cidara Therapeutics Inc.

Completed

A Single Ascending Dose Study of CD101 IV in Healthy Subjects

Healthy

United States
Cidara Therapeutics Inc.

Completed

An Ascending Multiple Dose Study of CD101 IV in Healthy Subjects

Healthy

United States
Cidara Therapeutics Inc.

Completed

CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension (STRIVE)

Mycoses | Candidemia | Fungemia | Fungal Infection | Invasive Candidiasis

United States, Spain, Belgium, Russian Federation, Greece, Bulgaria, Canada, Hungary, Italy, Romania

3

Subscribe